Compliance and Medicine

  • Bruce James Masek


Patient noncompliance with medical regimens has been the subject of considerable research. Several reviews of the literature have reported estimates of noncompliance ranging from 4% to 92% (Davis, 1966; Marston, 1970). The magnitude of the problem has prompted the suggestion that poor medical outcomes resulting from noncompliance might account for much of the current general dissatisfaction with the delivery of health care (Korsch & Negrete, 1972). In particular, noncompliance with medication regimens represents an immediate challenge to behavioral scientists because there now exist a number of highly effective drug therapies for various diseases. Patient noncompliance with prescribed medication regimens seriously undermines the effectiveness of drug therapy in both preventive and curative situations and results in unnecessary morbidity, mortality, and cost.


Rheumatic Fever Medication Compliance Apply Behavior Analysis Serum Diphenylhydantoin Peptic Ulcer Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Azrin, N. H., & Powell, J. Behavioral engineering: The use of response priming to improve prescribed self-medication. Journal of Applied Behavior Analysis, 1969, 2, 39–42PubMedCrossRefGoogle Scholar
  2. Baile, W. F., & Engel, B. T. A behavioral strategy for promoting treatment compliance following myocardial infarction. Psychosomatic Medicine, 1978, 40, 413–419.PubMedGoogle Scholar
  3. Ball, R. M. National health insurance: Comments on selected issues. Science, 1978, 200, 864–870.PubMedCrossRefGoogle Scholar
  4. Barnes, M. R. Token economy control of fluid overload in a patient receiving hemodialysis. Journal of Behavior Therapy and Experimental Psychiatry, 1976, 7, 305–306.CrossRefGoogle Scholar
  5. Bergsman, A. B., & Werner, R. J. Failure of children to receive penicillin by mouth. New England journal of Medicine, 1963, 268, 1334–1338.CrossRefGoogle Scholar
  6. Bigelow, G., Strickler, D., Liebson, I., & Griffiths, R. Maintaining disulfiram ingestion among outpatient alcoholics: A security-deposit contingency contracting procedure. Behavior Research and Therapy, 1976, 14, 378–381.CrossRefGoogle Scholar
  7. Blackwell, B. The drug defaulter. Clinical Pharmacology and Therapeutics, 1972, 13, 841848.Google Scholar
  8. Bonnar, J., Goldberg, A., & Smith, J. A. Do pregnant women take their iron? Lancet, 1969, 1, 457–458.PubMedCrossRefGoogle Scholar
  9. Brett, E. Implications of measuring anticonvulsant blood levels in epilepsy. Developmental Medicine and Child Neurology, 1977, 19, 245–251.PubMedCrossRefGoogle Scholar
  10. Brigg, E. H., & Mudd, E. H. An exploration of methods to reduce broken first appointments. Family Coordination, 1968, 17, 41–46.CrossRefGoogle Scholar
  11. Caron, H. S., & Roth, H. P. Patients’ cooperation with a medical regimen. Journal of the American Medical Association, 1968, 203, 120–124.CrossRefGoogle Scholar
  12. Chaves, A. Results of the P.A.S. urine test. American Review of Respiratory Diseases, 1960, 81, 111–119.Google Scholar
  13. Clinite, J., & Kabat, H. Improving patient compliance. Journal of the American Pharmacy Association, 1976, 16, 74–76.Google Scholar
  14. Culliton, B. J. Health care economics: The high cost of getting well. Science, 1978, 200, 883–885.PubMedCrossRefGoogle Scholar
  15. Dapcich-Miura, E., & Hovell, M. F. Contingency management of adherence to a complex medical regimen in an elderly heart patient. Journal of Applied Behavior Analysis, 1979, 10, 193–201.Google Scholar
  16. Davis, M. S. Variations in patient’s compliance with doctor’s orders: Analysis of congruence between survey responses and results of empirical investigations. Journal of Medical Education, 1966, 41, 1037–1048.PubMedGoogle Scholar
  17. Davis, M. S. Physiologic, psychological and demographic factors in patient compliance with doctor’s orders. Medical Care, 1968, 6, 115–122.CrossRefGoogle Scholar
  18. Epstein, L. H., & Masek, B. J. Behavioral control of medicine compliance. Journal of Applied Behavior Analysis, 1978, 11, 1–9.PubMedCrossRefGoogle Scholar
  19. Francis, V., Korsch, B. M., & Morris, M. J. Gaps in doctor-patient communication. New England journal of Medicine, 1969, 280, 535–540.PubMedCrossRefGoogle Scholar
  20. Goldsmith, C. H. The effect of differing compliance distributions on the planning and statistical analysis of therapeutic trials. In D. L. Sackett & R. B. Haynes (Eds.), Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press, 1976.Google Scholar
  21. Goodman, L. S. & Gilman, A. The pharmacological hn.cis of therapeutics. New York: Macmillan, 1980.Google Scholar
  22. Gordis, L. Conceptual and methodological problems in measuring patient compliance. In R. B. Hayes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.Google Scholar
  23. Gordis, L., Markowitz, M., & Lilienfield, A. M. The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Medical Care, 1969, 7, 49–54.PubMedCrossRefGoogle Scholar
  24. Gundert-Remy, U., Remy, C., & Weber, E. Serum digoxin levels in patients of a general practice in Germany. European Journal of Clinical Pharmacy, 1976, 10, 97–100.Google Scholar
  25. Haynes, R. B., Sackett, D. L., Gibson, E. S., Taylor, D. W., Hackett, B. C., Roberts, R. S., & Johnson, A. L. Improvement of medication compliance in uncontrolled hypertension. Lancet, 1976, 1, 1265–1268.PubMedCrossRefGoogle Scholar
  26. Haynes, S. N. Contingency management in a municipally administered antabuse program for alcoholics. Journal of Behavior Therapy and Experimental Psychiatry, 1974, 4, 31–32.CrossRefGoogle Scholar
  27. Irwin, D. S., Weitzell, W. D., & Morgan, D. W. Phenothiazine intake and staff attitudes. American Journal of Psychiatry, 1971, 127, 1631–1635.PubMedGoogle Scholar
  28. Joyce, C. R. B. Patient cooperation and the sensitivity of clinical trials. Journal of Chronic Diseases, 1962, 15, 1025–1036.CrossRefGoogle Scholar
  29. Korsch, B. M., & Negrete, V. F. Doctor-patient communication. Scientific American, August 1972, 66–74.Google Scholar
  30. Lasky, J. L. The problem of sample attrition in controlled treatment trials. Journal of Nervous and Mental Diseases, 1962, 135, 332–337.CrossRefGoogle Scholar
  31. Lendrum, B., & Korbin, C. Prevention of recurrent attacks of rheumatic fever: Problems revealed by long-term follow-up. Journal of the American Medical Association, 1956, 162, 13–16.PubMedCrossRefGoogle Scholar
  32. Linkewich, J. A., Catalano, R. B., & Flack, H. L. The effect of packaging and instruction in out-patient compliance with medication regimens. Drug Intelligence in Clinical Pharmacy, 1974, 8, 10–15.Google Scholar
  33. Lipman, R. S., Rickels, K., Uhlenhuth, E. H., Park, L. C., & Fisher, S. Neurotics who fail to take their drugs. British Journal of Psychiatry, 1965, 111, 1043–1049.PubMedCrossRefGoogle Scholar
  34. Lowe, D., & Lutker, J. F. Increasing compliance in a medical regimen with a juvenile diabetic. Behavior Therapy, 1979, 10, 57–64.CrossRefGoogle Scholar
  35. Lund, M., Jorgensen, R. S., & Kuhl, V. Serum diphenylhydantoin (Dilantin) in ambulant patients with epilepsy. Epilepsy, 1964, 5, 51–58.CrossRefGoogle Scholar
  36. Luntz, R. W. A., & Austin, R. New stick test for P.A.S. in urine. British Medical Journal, 1960, 1, 1679–1682.PubMedCrossRefGoogle Scholar
  37. Magrab, P. R., & Papadopoulou, Z. L. The effect of a token economy on dietary compliance for children on hemodialysis. Journal of Applied Behavior Analysis, 1977, 10, 573–578.PubMedCrossRefGoogle Scholar
  38. Malahey, B. The effects of instructions and labeling on the number of medication errors made by patients at home. American Journal of Hospital Pharmacy, 1966, 23, 283–292.Google Scholar
  39. Marston, M. V. Compliance with medical regimens: A review of the literature. Nursing Research, 1970, 19, 312–323.PubMedCrossRefGoogle Scholar
  40. Masek, B. J., Cataldo, M. F., Freeman, J., & Roulston, D. Behavioral control of compliance with anticonvulsant drug regimens. Behavior Therapist, in press.Google Scholar
  41. Masek, B. J., Epstein, L. H., & Russo, D. C. Behavioral perspectives in preventive medicine. In S. Turner, K. Calhoun, & H. Adams (Eds.), Handbook of clinical behavior therapy. New York: Wiley, 1981.Google Scholar
  42. McInnis, J. K. Do patients take antituberculosis drugs? American journal of Nursing, 1970, 70, 2152–2153.PubMedGoogle Scholar
  43. Melchoir, J. C. The clinical use of serum determinants of phenytoin and phenobarbital in children. Developmental Medicine and Child Neurology, 1965, 7, 387–391.CrossRefGoogle Scholar
  44. Moulding, T. Proposal for a time-recording pill dispenser as a method for studying and supervising the self-administration of drugs. American Review of Respiratory Diseases, 1962, 85, 754–757.Google Scholar
  45. Park, L. C., & Lipman, R. S. A comparison of patient dosage deviation reports with pill counts. Psychopharmacologia, 1964, 6, 299–302.PubMedCrossRefGoogle Scholar
  46. Parker, L. C., & Bender, L. F. Problems of home treatment in arthritics. Archives of Physical Medicine, 1957, 38, 392–394.Google Scholar
  47. Penry, J. K. Reliability of serum antiepileptic drug concentrations and patient management. In C. E. Pippenger, J. K. Penry, & H. Kutt (Eds.), Antiepileptic drugs: Quantitative analysis and interpretation. New York: Raven Press, 1978.Google Scholar
  48. Pippenger, C. E., Penry, J. K., & Kutt, H. (Eds.). Antiepileptic drugs: Quantitative analysis and interpretation. New York: Raven Press, 1978.Google Scholar
  49. Porter, A. M. W. Drug defaulting in general practice. British Medical Journal, 1969, 1, 218–222.PubMedCrossRefGoogle Scholar
  50. Preston, D. F., & Miller, F. L. The tuberculosis outpatients’ defection from therapy. American Journal of Medical Science, 1964, 247, 21–25.CrossRefGoogle Scholar
  51. Richens, A. Quality control of drug estimations. Acta Neurologica Scandinavica, 1975, 60, 81–84.CrossRefGoogle Scholar
  52. Rickels, K., & Briscoe, E. Assessment of dosage deviation in outpatient drug research. Journal of Clinical Pharmacology, 1970, 10, 153–160.Google Scholar
  53. Rickels, K., Boren, R., & Stuart, H. M. Controlled psychopharmacological research in general practice. Journal of New Drugs, 1964, 4, 138–147.Google Scholar
  54. Roth, H. P., & Berger, D. G. Studies on patient cooperation in ulcer treatment. I. Observation of actual as compared to prescribed antacid intake on a hospital ward. Gastroenterology, 1960, 38, 630–633.PubMedGoogle Scholar
  55. Roth, H. P., Caron, H. S., & Hsi, B. P. Measuring intake of prescribed medication: A bottle count and a tracer technique compared. Clinical Pharmacology and Therapeutics, 1970, 11,228–237.PubMedGoogle Scholar
  56. Roth, H. P., Caron, H. S., & Hsi, B. P. Estimating a patient’s cooperation with his regimen. American Journal of Medical Science, 1971, 262, 269.CrossRefGoogle Scholar
  57. Ryan, W. L., Carver, M. J., & Haller, J. Phenolsulfonthalein as an index of drug ingestion. American Journal of Pharmacy, 1962, 134, 168–171.Google Scholar
  58. Sackett, D. L., & Haynes, R. B. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press, 1976.Google Scholar
  59. Sackett, D. L., & Snow, J. C. The magnitude of compliance and noncompliance. In R. B. Hayes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.Google Scholar
  60. Sackett, D. L., Haynes, R. B., Gibson, E. S., Hackett, B. C., Taylor, D. W., Roberts, R. S., & Johnson, A. L. Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet, 1975, 1, 7918–7920.Google Scholar
  61. Sherwin, A. L., Robb, J. P., & Lechter, M. Improved control of epilepsy by monitoring plasma ethosuximide. Archives of Neurology, 1973, 28, 178–181.PubMedCrossRefGoogle Scholar
  62. Shmarak, K. L. Reduce your broken appointment rate: How one children and youth project reduced its broken appointment rate. American Journal of Public Health, 1971, 61, 2400–2404.PubMedCrossRefGoogle Scholar
  63. Soutter, R. B., & Kennedy, M. C. Patient compliance assessment in drug trials: Usage and methods. Austrailian and New Zealand Journal of Medicine,1974, 4, 360–364.CrossRefGoogle Scholar
  64. Turner, A. J., & Vernon, J. C. Prompts to increase attendance in a community mental health center. Journal of Applied Behavior Analysis, 1976, 9, 141–145.PubMedCrossRefGoogle Scholar
  65. Walsh, J. Federal spending passes the $50-billion mark. Science 1978, 200, 886–887.PubMedCrossRefGoogle Scholar
  66. Willcox, D. R. C., Gillan, R., & Hare, E. H. Do psychiatric patients take their drugs? British journal of Medicine, 1965, 2, 790–792.CrossRefGoogle Scholar
  67. Wilson, J. D., & Enoch, M. D. Estimation of drug rejection by schizophrenic in-patients, with analysis of clinical factors. British Journal of Psychiatry, 1967, 113, 209–211.PubMedCrossRefGoogle Scholar
  68. Wynn-Williams, N., & Avis, M. On omitting P.A.S. Tubercule, 1958, 39, 138–142.CrossRefGoogle Scholar
  69. Zifferblatt, S. M. Increasing patient compliance through the applied analysis of behavior. Preventive Medicine, 1975, 4, 173–182.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Bruce James Masek
    • 1
  1. 1.Department of PsychiatryHarvard Medical SchoolBostonUSA

Personalised recommendations